A Systematic Analysis of Physicochemical and ADME Properties of All Small Molecule Kinase Inhibitors Approved by US FDA from January 2001 to October 2015.

Abstract:

BACKGROUND:During lead identification and optimization, the advancement criteria may be driven based on scientific principles, prior experiences, and/or by examining the path paved by approved drugs. However, accessing the discovery data on physicochemical and ADME properties of the approved kinase inhibitors is a monumental task as these are either scattered in the literature or have not been published. OBJECTIVE:Our goals were: 1) To compile the relevant data on all kinase inhibitors approved prior to 2016 for easy access by the biopharmaceutical community, 2) To provide a retrospective analysis to highlight trends and attributes which may have contributed to the "developability" of these drugs, and 3) To ignite focused debates on what constitutes "actionable", "nice-to-have", and unnecessary data. Such debates bring about more clarity on stage appropriateness of different types of information and prevent confusion due to abundance of unnecessary data, leading to more efficient and less costly drug discovery programs. METHODS:A careful and thorough analysis of different bodies of data such as published manuscripts, and available regulatory documents were employed. RESULTS:We were able to assemble a large body of data on the first thirty kinase inhibitors approved by US FDA since 2001. CONCLUSION:In conclusion, we have compiled physicochemical and ADME data on the first 30 approved kinase inhibitors and provided our retrospective analysis, which we hope is helpful in constructing advancement criteria in discovery programs. The examination of this data provides an opportunity to develop an opinion on data prioritization and stage appropriateness of assays.

journal_name

Curr Med Chem

authors

O Brien Z,Moghaddam MF

doi

10.2174/0929867324666170523124441

subject

Has Abstract

pub_date

2017-01-01 00:00:00

pages

3159-3184

issue

29

eissn

0929-8673

issn

1875-533X

pii

CMC-EPUB-83631

journal_volume

24

pub_type

杂志文章,评审
  • DNA damage repair and response proteins as targets for cancer therapy.

    abstract::The cellular response to DNA damage is critical for determining whether carcinogenesis, cell death or other deleterious biological effects will ensue. Numerous cellular enzymatic mechanisms can directly repair damaged DNA, or allow tolerance of DNA lesions, and thus reduce potential harmful effects. These processes in...

    journal_title:Current medicinal chemistry

    pub_type: 杂志文章,评审

    doi:10.2174/092986708783497328

    authors: Lieberman HB

    更新日期:2008-01-01 00:00:00

  • Neurotrophic factors--a tool for therapeutic strategies in neurological, neuropsychiatric and neuroimmunological diseases?

    abstract::Nerve growth factor (NGF) and brain-derived neurotrophic factor (BDNF) belong to the protein family of neurotrophins. They both display profound neuromodulatory functions and are essentially involved in the survival and homeostatic maintenance of central and peripheral neurons during development and adulthood. Moreove...

    journal_title:Current medicinal chemistry

    pub_type: 杂志文章,评审

    doi:10.2174/092986707781745578

    authors: Schulte-Herbrüggen O,Braun A,Rochlitzer S,Jockers-Scherübl MC,Hellweg R

    更新日期:2007-01-01 00:00:00

  • Taking advantage of viral immune evasion: virus-derived proteins represent novel biopharmaceuticals.

    abstract::In healthy individuals, natural and adaptive immune responses are able to control virus entry into the host. In particular, CD8(+)-mediated cytotoxicity, sustained by the intervention of CD4+ cells, represents the major key event leading to virus eradication. On the other hand, viruses are able to evade from host immu...

    journal_title:Current medicinal chemistry

    pub_type: 杂志文章,评审

    doi:10.2174/092986706775476106

    authors: Amati L,Passeri ME,Lippolis A,Lio D,Caruso C,Jirillo E,Covelli V

    更新日期:2006-01-01 00:00:00

  • Current knowledge on the antagonists and inverse agonists of cannabinoid receptors.

    abstract::Ten years elapsed since the discovery by Sanofi of SR141716A the first selective CB(1) cannabinoid receptor antagonist. Shortly after, Sanofi also reported the synthesis of the first selective CB(2) cannabinoid receptor antagonist, SR144528. Since these two milestones in the cannabinoid field, many other compounds, mo...

    journal_title:Current medicinal chemistry

    pub_type: 杂志文章,评审

    doi:10.2174/0929867054020891

    authors: Muccioli GG,Lambert DM

    更新日期:2005-01-01 00:00:00

  • The influence of a half-marathon race upon cardiac troponin T release in adolescent runners.

    abstract:OBJECTIVES:Post-exercise cardiac troponin T (cTnT) release has been widely reported in adult athletes but limited data is available for adolescents. The aim of this study was to determine the incidence and magnitude of cTnT appearance in a large group of adolescent runners, and to determine any association between cTnT...

    journal_title:Current medicinal chemistry

    pub_type: 杂志文章

    doi:10.2174/092986711796642625

    authors: Nie J,George KP,Tong TK,Gaze D,Tian Y,Lin H,Shi Q

    更新日期:2011-01-01 00:00:00

  • mTOR inhibitors (rapamycin and its derivatives) and nitrogen containing bisphosphonates: bi-functional compounds for the treatment of bone tumours.

    abstract::N-BP, rapamycin and its derivatives have been originally developed respectively as anti-resorptive and anti-fungal agents. In fact, in vitro and in vivo experiments demonstrated that these compounds are multi-functional molecules exerting their effects on tumour cell growth and bone remodelling. The major challenge in...

    journal_title:Current medicinal chemistry

    pub_type: 杂志文章,评审

    doi:10.2174/092986707780831159

    authors: Ory B,Moriceau G,Redini F,Heymann D

    更新日期:2007-01-01 00:00:00

  • Insights on Nutrients as Analgesics in Chronic Pain.

    abstract::Many serious inflammatory disorders and nutrient deficiencies induce chronic pain, and anti-inflammatory diets have been applied successfully to modify the inflammatory symptoms causing chronic pain. Numerous scientific data and clinical investigations have demonstrated that long-term inflammation could lead to an ina...

    journal_title:Current medicinal chemistry

    pub_type: 杂志文章,评审

    doi:10.2174/0929867326666190712172015

    authors: Bjørklund G,Chirumbolo S,Dadar M,Pen JJ,Doşa MD,Pivina L,Semenova Y,Aaseth J

    更新日期:2020-01-01 00:00:00

  • New therapeutic strategies for coeliac disease: tissue transglutaminase as a target.

    abstract::Coeliac disease is a multifactorial disease characterized by a dysregulated immune response to ingested wheat gluten and related cereal proteins. With an incidence of about 1% of the general population, it is considered the most common food intolerance disorder. The mainstay of coeliac disease treatment is strict life...

    journal_title:Current medicinal chemistry

    pub_type: 杂志文章,评审

    doi:10.2174/092986707782023343

    authors: Esposito C,Caputo I,Troncone R

    更新日期:2007-01-01 00:00:00

  • Human terminal deoxynucleotidyl transferases as novel targets for anticancer chemotherapy.

    abstract::Mammalian terminal deoxyribonucleotidyl transferase (TDT) catalyzes the non-template-directed polymerization of deoxyribonucleoside triphosphates and has a key role in V(D)J recombination during lymphocyte and repertoire development. Over 90% of leukemic cells in acute lymphocytic leukemia and approximately 30% of leu...

    journal_title:Current medicinal chemistry

    pub_type: 杂志文章,评审

    doi:10.2174/092986706777935087

    authors: Di Santo R,Maga G

    更新日期:2006-01-01 00:00:00

  • Pharmacological implications of MMP-9 inhibition by ACE inhibitors.

    abstract::Matrix metalloproteinase-9 (MMP-9) plays an important role in the onset and prognosis of myocardial infarction. Targets of angiotensin converting enzyme (ACE) inhibitors might include not only ACE but also MMP-9, and ACE seems to be closely associated with complications of hypertension such as cardiovascular remodelin...

    journal_title:Current medicinal chemistry

    pub_type: 杂志文章

    doi:10.2174/092986709787846514

    authors: Yamamoto D,Takai S

    更新日期:2009-01-01 00:00:00

  • Marine Natural Products with High Anticancer Activities.

    abstract::This review covers recent literature from 2012-2019 concerning 170 marine natural products and their semisynthetic analogues with strong anticancer biological activities. Reports that shed light on cellular and molecular mechanisms and biological functions of these compounds, thus advancing the understanding in cancer...

    journal_title:Current medicinal chemistry

    pub_type: 杂志文章,评审

    doi:10.2174/0929867327666200113154115

    authors: Matulja D,Wittine K,Malatesti N,Laclef S,Turks M,Markovic MK,Ambrožić G,Marković D

    更新日期:2020-01-01 00:00:00

  • Small molecule inhibitors of STAT3 for cancer therapy.

    abstract::Aberrant activation of the signal transducer and activator of transcription (STAT) 3 occurs in many human tumors. Constitutive STAT3 activity induces specific target genes that stimulate cell proliferation, prevent apoptosis, promote angiogenesis and facilitate tumor immune evasion. Thus, STAT3 is an attractive molecu...

    journal_title:Current medicinal chemistry

    pub_type: 杂志文章,评审

    doi:10.2174/092986711796957284

    authors: Zhao M,Jiang B,Gao FH

    更新日期:2011-01-01 00:00:00

  • Developing FGFR4 inhibitors as potential anti-cancer agents via in silico design, supported by in vitro and cell-based testing.

    abstract::Fibroblast growth factor receptor-4 (FGFR4) is a tyrosine kinase with a range of important physiological functions. However, it is also frequently mutated in various cancers and is now generating significant interest as a potential therapeutic target. Unfortunately, biochemical characterization of its role in disease,...

    journal_title:Current medicinal chemistry

    pub_type: 杂志文章

    doi:10.2174/0929867311320100001

    authors: Ho HK,Németh G,Ng YR,Pang E,Szántai-Kis C,Zsákai L,Breza N,Greff Z,Horváth Z,Pató J,Szabadkai I,Szokol B,Baska F,Őrfî L,Ullrich A,Kéri G,Chua BT

    更新日期:2013-01-01 00:00:00

  • Sarcopenia, Aging and Prospective Interventional Strategies.

    abstract::Sarcopenia, or age-related muscle decline, occurs in most organisms and burdens both human health and the healthcare system. As our population ages, additional options for treating sarcopenia are needed. Mitochondrial dysfunction is implicated in the onset of sarcopenia, so therapies directed at improving mitochondria...

    journal_title:Current medicinal chemistry

    pub_type: 杂志文章,评审

    doi:10.2174/0929867324666170801095850

    authors: Waltz TB,Fivenson EM,Morevati M,Li C,Becker KG,Bohr VA,Fang EF

    更新日期:2018-01-01 00:00:00

  • Neurotrophins' Modulation by Olive Polyphenols.

    abstract:BACKGROUND:Polyphenols are probably the most known and investigated molecules of nutritional interest as micronutrients present in abundance in our diet. Some of the most important food sources of polyphenols in the Mediterranean diet are olives and olive oil. A growing body of evidence from animal models to clinical s...

    journal_title:Current medicinal chemistry

    pub_type: 杂志文章,评审

    doi:10.2174/0929867323666160627104022

    authors: Carito V,Ceccanti M,Tarani L,Ferraguti G,Chaldakov GN,Fiore M

    更新日期:2016-01-01 00:00:00

  • Structure Properties and Mechanisms of Action of Naturally Originated Phenolic Acids and Their Derivatives against Human Viral Infections.

    abstract:BACKGROUND:A great effort has been made to develop efficacious antiviral drugs, but many viral infections are still lack of efficient antiviral therapies so far. The related exploration of natural products to fight viruses has been raised in recent years. Natural compounds with structural diversity and complexity offer...

    journal_title:Current medicinal chemistry

    pub_type: 杂志文章,评审

    doi:10.2174/0929867324666170815102917

    authors: Wu YH,Zhang BY,Qiu LP,Guan RF,Ye ZH,Yu XP

    更新日期:2017-01-01 00:00:00

  • The hemostatic system.

    abstract::The hemostatic system comprises platelet aggregation, coagulation and fibrinolysis also termed primary, secondary and tertiary hemostasis. From the platelet transcriptome 6000 mRNA species and represent receptors, ion channels, signalling molecules, kinases, phosphatases, and structural, metabolic and regulatory prote...

    journal_title:Current medicinal chemistry

    pub_type: 杂志文章,评审

    doi:10.2174/0929867043364603

    authors: Stassen JM,Arnout J,Deckmyn H

    更新日期:2004-09-01 00:00:00

  • Targeting Kinetoplastid and Apicomplexan Thymidylate Biosynthesis as an Antiprotozoal Strategy.

    abstract::Kinetoplastid and apicomplexan parasites comprise a group of protozoans responsible for human diseases, with a serious impact on human health and the socioeconomic growth of developing countries. Chemotherapy is the main option to control these pathogenic organisms and nucleotide metabolism is considered a promising a...

    journal_title:Current medicinal chemistry

    pub_type: 杂志文章,评审

    doi:10.2174/0929867325666180926154329

    authors: Valente M,Vidal AE,González-Pacanowska D

    更新日期:2019-01-01 00:00:00

  • Visible Blue Light Therapy: Molecular Mechanisms and Therapeutic Opportunities.

    abstract:BACKGROUND:Visible light is absorbed by photoacceptors in pigmented and non-pigmented mammalian cells, activating signaling cascades and downstream mechanisms that lead to the modulation of cellular processes. Most studies have investigated the molecular mechanisms and therapeutic applications of UV and the red to near...

    journal_title:Current medicinal chemistry

    pub_type: 杂志文章,评审

    doi:10.2174/0929867324666170727112206

    authors: Garza ZCF,Born M,Hilbers PAJ,van Riel NAW,Liebmann J

    更新日期:2018-01-01 00:00:00

  • The Use of Stilbene Scaffold in Medicinal Chemistry and Multi- Target Drug Design.

    abstract::The stilbene scaffold is a basic element for a number of biologically active natural and synthetic compounds, and it is considered as a privileged structure. Stilbenes exemplified by resveratrol, combretastatin A-4 and pterostilbene are of significant interest for drug research and development because of their potenti...

    journal_title:Current medicinal chemistry

    pub_type: 杂志文章,评审

    doi:10.2174/0929867323666160517121629

    authors: Giacomini E,Rupiani S,Guidotti L,Recanatini M,Roberti M

    更新日期:2016-01-01 00:00:00

  • The Chronicle of COVID-19 and Possible Strategies to Curb the Pandemic

    abstract::COVID-19, a type of infection that emerged in Wuhan, has become a pandemic affecting people worldwide and is rapidly spreading and evolving. Day by day, the confirmed cases and deaths are increasing many folds. SARS-CoV-2 is a novel virus; therefore, limited data are available to curb the disease. Epidemiological appr...

    journal_title:Current medicinal chemistry

    pub_type: 杂志文章

    doi:10.2174/0929867327666200702151018

    authors: Kumar R,Harilal S,Al-Sehemi AG,Mathew GE,Carradori S,Mathew B

    更新日期:2020-07-02 00:00:00

  • Intravenous and regional paclitaxel formulations.

    abstract::Paclitaxel has been proven to be effective against different types of cancer. A delivery system loaded with paclitaxel at tumor site should provide a high local concentration of the drug detrimental to malignant cells, which prevents the re-growth and metastasis of tumor. In this review, paclitaxel formulations for sy...

    journal_title:Current medicinal chemistry

    pub_type: 杂志文章,评审

    doi:10.2174/0929867043455981

    authors: Pawar R,Shikanov A,Vaisman B,Domb AJ

    更新日期:2004-02-01 00:00:00

  • Medicinal electrochemistry: integration of electrochemistry, medicinal chemistry and computational chemistry.

    abstract::Over the last centuries, there were many important discoveries in medicine that were crucial for gaining a better understanding of several physiological processes. Molecular modelling techniques are powerful tools that have been successfully used to analyse and interface medicinal chemistry studies with electrochemica...

    journal_title:Current medicinal chemistry

    pub_type: 杂志文章,评审

    doi:10.2174/0929867321666140217120655

    authors: Almeida MO,Maltarollo VG,de Toledo RA,Shim H,Santos MC,Honorio KM

    更新日期:2014-01-01 00:00:00

  • miRNA: small molecules as potential novel biomarkers in cancer.

    abstract::Four different types of small RNAs functionally associated with gene silencing have been discovered in animals including small interfering RNAs (siRNAs), microRNAs (miRNAs), and Piwi-interacting RNAs (piRNAs). Experimental evidence suggests that miRNAs regulate the expression of more than 30% of protein-coding genes. ...

    journal_title:Current medicinal chemistry

    pub_type: 杂志文章,评审

    doi:10.2174/092986710794182980

    authors: Shah AA,Leidinger P,Blin N,Meese E

    更新日期:2010-01-01 00:00:00

  • Relevance of dopamine D(2)/neurotensin NTS1 and NMDA/neurotensin NTS1 receptor interaction in psychiatric and neurodegenerative disorders.

    abstract::The existence of functional NT/dopamine interactions in the central nervous system has been extensively documented. Among others, a possible molecular mechanism underlying the NT-induced modulation of dopamine release is a direct antagonistic NTS(1)/D(2) receptor interaction. More recently, neurochemical experiments a...

    journal_title:Current medicinal chemistry

    pub_type: 杂志文章,评审

    doi:10.2174/092986712803414268

    authors: Tanganelli S,Antonelli T,Tomasini MC,Beggiato S,Fuxe K,Ferraro L

    更新日期:2012-01-01 00:00:00

  • Molecular anatomy of the brain endothelial barrier: an overview of the distributional features.

    abstract::The blood-brain barrier (BBB) impedes the influx of intravascular compounds from the blood to the brain. The elements composing the BBB are endothelial cells, pericytes and the end-feet of astrocytes. Among them, the endothelial cell barrier line is the most critical for preventing toxic substances from entering the b...

    journal_title:Current medicinal chemistry

    pub_type: 杂志文章,评审

    doi:10.2174/092986707780597943

    authors: Ueno M

    更新日期:2007-01-01 00:00:00

  • Multi-aspect candidates for repositioning: data fusion methods using heterogeneous information sources.

    abstract::Drug repositioning, an innovative therapeutic application of an old drug, has received much attention as a particularly costeffective strategy in drug R&D Recent work has indicated that repositioning can be promoted by utilizing a wide range of information sources, including medicinal chemical, target, mechanism, main...

    journal_title:Current medicinal chemistry

    pub_type: 杂志文章

    doi:

    authors: Arany Á,Bolgár B,Balogh B,Antal P,Mátyus P

    更新日期:2013-01-01 00:00:00

  • The current status of sweat testing for drugs of abuse: a review.

    abstract::Sweat is an alternative biological matrix useful to detect drugs of abuse intake. It is produced by eccrine and apocrine glands originating in the skin dermis and terminating in secretory canals that flow into the skin surface and hair follicles. Since many years it has been demonstrated that endogenous and exogenous ...

    journal_title:Current medicinal chemistry

    pub_type: 杂志文章,评审

    doi:10.2174/0929867311320040006

    authors: De Giovanni N,Fucci N

    更新日期:2013-01-01 00:00:00

  • Collagenolytic Enzymes and their Applications in Biomedicine.

    abstract::Nowadays, enzymatic therapy is a very promising line of treatment for many different diseases. There is a group of disorders and conditions, caused by fibrotic and scar processes and associated with the excessive accumulation of collagen that needs to be catabolized to normalize the connective tissue content. The huma...

    journal_title:Current medicinal chemistry

    pub_type: 杂志文章,评审

    doi:10.2174/0929867324666171006124236

    authors: Shekhter AB,Balakireva AV,Kuznetsova NV,Vukolova MN,Litvitsky PF,Zamyatnin AA Jr

    更新日期:2019-01-01 00:00:00

  • Targeting Ceramide Metabolism in Hepatocellular Carcinoma: New Points for Therapeutic Intervention.

    abstract:BACKGROUND:Hepatocellular Carcinoma (HCC) is one of the greatest global health burdens because of its uncontrolled cell growth and proliferation, aggressive nature as well as inherited chemoresistance. In spite of different treatment options currently available for HCC, the 5-year relative survival rates for HCC patien...

    journal_title:Current medicinal chemistry

    pub_type: 杂志文章,评审

    doi:10.2174/0929867326666190911115722

    authors: Grbčić P,Car EPM,Sedić M

    更新日期:2020-01-01 00:00:00